At the molecular level, the overexpression of the WNT-selective receptor ROR2 upregulates some non-classical WNT ligands, especially WNT11, and ligand-receptor binding regulated various functional proteins, increasing the invasiveness of breast cancer brain metastases [54]. This evidence concerns the gene ROR2 and breast cancer.